Try our Advanced Search for more refined results
March 26, 2018
Securities And Exchange Commission v. Akorn, Inc. et al
Case Number:
1:18-cv-02150
Court:
Nature of Suit:
Judge:
Companies
Government Agencies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
March 26, 2018
SEC Settles With Drugmaker Akorn Over Revenue Reports
Generic-drug maker Akorn Inc. and two of its former executives formally settled with the U.S. Securities and Exchange Commission Monday over false financial statements Akorn made in 2014 that overstated the company's revenue.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login